↓ Skip to main content

Mosquito Akirin as a potential antigen for malaria control

Overview of attention for article published in Malaria Journal, December 2014
Altmetric Badge

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
53 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mosquito Akirin as a potential antigen for malaria control
Published in
Malaria Journal, December 2014
DOI 10.1186/1475-2875-13-470
Pubmed ID
Authors

Mário da Costa, Renato Pinheiro-Silva, Sandra Antunes, Juan A Moreno-Cid, Ana Custódio, Margarita Villar, Henrique Silveira, José de la Fuente, Ana Domingos

Abstract

The control of vector-borne diseases is important to improve human and animal health worldwide. Malaria is one of the world's deadliest diseases and is caused by protozoan parasites of the genus Plasmodium, which are transmitted by Anopheles spp. mosquitoes. Recent evidences using Subolesin (SUB) and Akirin (AKR) vaccines showed a reduction in the survival and/or fertility of blood-sucking ectoparasite vectors and the infection with vector-borne pathogens. These experiments suggested the possibility of using AKR for malaria control.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 4%
Chile 1 2%
Unknown 50 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 15%
Student > Master 7 13%
Student > Postgraduate 6 11%
Student > Ph. D. Student 5 9%
Student > Doctoral Student 5 9%
Other 15 28%
Unknown 7 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 15 28%
Medicine and Dentistry 10 19%
Veterinary Science and Veterinary Medicine 5 9%
Biochemistry, Genetics and Molecular Biology 5 9%
Nursing and Health Professions 1 2%
Other 6 11%
Unknown 11 21%